Novel investigational drugs active as single agents in multiple myeloma
Sign Up to like & getrecommendations! Published in 2017 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2017.1324571
Abstract: ABSTRACT Introduction: Multiple myeloma (MM) is a hematologic malignancy characterized by proliferation of malignant plasma cells. patient outcome has improved markedly over the last decades due to the introduction of novel therapeutic agents such as… read more here.
Keywords: multiple myeloma; investigational drugs; agent activity; single agent ... See more keywords
Idronoxil as an Anticancer Agent: Activity and Mechanisms.
Sign Up to like & getrecommendations! Published in 2020 at "Current cancer drug targets"
DOI: 10.2174/1568009620666200102122830
Abstract: Idronoxil has been the subject of more than 50 peer reviewed publications over the last two decades. This isoflavone is an intriguing regulator of multiple signal transduction pathways, capable of causing a range of biological… read more here.
Keywords: agent activity; activity mechanisms; anticancer agent; mechanisms idronoxil ... See more keywords